Traumatic Brain Injuries Assessment and Management Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

The Global Traumatic Brain Injuries Assessment And Management Devices Market is projected to expand from a valuation of USD 3.78 billion in 2025 to USD 5.76 billion by 2031, reflecting a compound annual growth rate of 7.27%. This market sector comprises diagnostic apparatus and therapeutic systems intended to assess and manage intracranial trauma caused by external impact, with key product offerings ranging from intracranial pressure monitors to advanced neuroimaging equipment and targeted temperature management solutions. The primary factors fueling this growth include the escalating global frequency of road traffic accidents and the rising number of fall-related injuries within the aging population, alongside intensified protocols for sports-related concussions that drive the need for accurate on-field assessment instruments.

However, the market faces a substantial hurdle due to the prevalent underdiagnosis of mild brain injuries, a factor that frequently delays medical intervention and restricts device usage. This lack of recognition severely curtails the implementation of diagnostic technologies outside of critical care environments. Data from the Brain Injury Association of America indicates that in 2025, 81% of adults in the United States failed to identify concussions as traumatic brain injuries. This profound gap in awareness obstructs early detection efforts and stands as a significant impediment to the wider adoption and expansion of assessment solutions.

Market Drivers

The growing integration of neuro-trauma solutions within military and defense sectors serves as a robust engine for market growth, propelled by the urgent necessity for rapid, field-ready assessment capabilities in combat and training scenarios. Defense entities are emphasizing the procurement of ruggedized handheld units and serum biomarker assays to effectively manage blast-induced neurotrauma and mitigate long-term neurological damage among personnel, creating a demand for technologies that function reliably outside standard clinical facilities. As highlighted by the Military Health System in August 2025, the '2024 DOD Worldwide Numbers for TBI' report documented 18,376 new traumatic brain injury diagnoses among active-duty service members in 2024, confirming the defense sector's pivotal role as a major purchaser of early-detection and management devices.

Concurrently, supportive government programs and public awareness campaigns are transforming the market by enhancing the identification of mild traumatic brain injuries that were previously overlooked. These educational initiatives empower individuals to recognize symptoms and pursue medical care, thereby expanding the patient population eligible for assessment and therapy. According to the Brain Injury Association of America's '2025 Public Perceptions of Brain Injury Report' released in March 2025, nearly four out of ten U.S. adults acknowledged experiencing brain injury symptoms, signaling significant market potential if these latent cases are brought into the clinical fold. This trend toward proactive management is also reflected in professional sports; the NFL reported in February 2025 that stricter safety mandates resulted in a record low of 182 concussions during the 2024 season, proving that rigorous assessment protocols are successfully reducing injury risks.

Market Challenges

A major obstacle obstructing the growth of the Global Traumatic Brain Injuries Assessment and Management Devices Market is the pervasive underdiagnosis of mild brain injuries. This issue establishes a considerable disparity between the actual occurrence of intracranial trauma and the number of patients who receive clinical care; when symptoms are ignored or not immediately linked to neurological trauma, the avenue for employing diagnostic tools and therapeutic systems is effectively closed. As a result, the utilization of assessment technologies remains disproportionately focused in high-acuity trauma centers, preventing the market from extending into primary care facilities, sports medicine clinics, and outpatient rehabilitation centers where broader adoption is possible.

This inability to accurately identify patients directly curbs the demand for diagnostic technologies. Data from the Brain Injury Association of America in 2025 reveals that fewer than one in four adults in the United States reported being questioned by a healthcare provider regarding a history of brain injury. Such a low frequency of clinical inquiry implies that a multitude of potential cases go uninvestigated. Consequently, as long as routine screening remains uncommon, the downstream application of neuroimaging modalities and monitoring devices will fail to match the actual medical necessity, thereby directly impeding revenue generation for manufacturers within this industry.

Market Trends

The incorporation of Artificial Intelligence and Machine Learning for Predictive Analytics is transforming neurotrauma care by automating the recognition of severe intracranial anomalies. Sophisticated algorithms are increasingly being integrated into diagnostic workflows to swiftly detect and quantify brain injuries based on imaging data, substantially shortening the time to treatment for urgent conditions. This technological advancement facilitates the concurrent analysis of various biomarkers and imaging modalities, offering clinicians instant, data-backed decision support. For instance, in October 2025, Qure.ai announced in a press release regarding its '19th FDA Clearance' that it received approval for the qER-CTA algorithm, an AI tool engineered to aid in the rapid triage of neurocritical cases, thereby broadening its suite of solutions for automatically detecting intracranial hemorrhages and acute brain emergencies.

Parallel to these AI developments, the proliferation of Handheld and Point-of-Care Diagnostic Devices is extending the scope of TBI assessment into non-hospital settings. These portable units permit the immediate assessment of intracranial bleeding in resource-constrained environments, such as remote locations or ambulances, where access to conventional computed tomography is limited. By leveraging technologies such as near-infrared spectroscopy, these devices facilitate dependable on-site screening that supports rapid patient triage. As reported by the University of Cambridge in a July 2025 research publication titled 'Performance of the InfraScanner', the handheld InfraScanner 2000 exhibited a negative predictive value of 94.2% for detecting intracranial bleeding in trauma patients, highlighting its value as a frontline triage instrument when comprehensive neuroimaging is inaccessible.

Key Players Profiled in the Traumatic Brain Injuries Assessment And Management Devices Market

• Integra LifeSciences Corp
• BioDirection Inc.
• Nihon Kohden Tokyo Corp
• Compumedics Ltd.
• InfraScan Inc.
• Oculogica Inc.
• RAUMEDIC AG

Report Scope

In this report, the Global Traumatic Brain Injuries Assessment And Management Devices Market has been segmented into the following categories:

Traumatic Brain Injuries Assessment And Management Devices Market, by Devices:

• Imaging Devices (Magnetic Resonance Imaging (MRI) Devices, X-Ray, Computed Tomography, Others)
• Monitoring Devices

Traumatic Brain Injuries Assessment And Management Devices Market, by Technique:

• Intracranial pressure monitoring
• Partial pressure of oxygen in brain tissue (pBrO2)

Traumatic Brain Injuries Assessment And Management Devices Market, by End-Use:

• Hospitals
• Diagnostic centers
• Others

Traumatic Brain Injuries Assessment And Management Devices Market, by Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Traumatic Brain Injuries Assessment And Management Devices Market.

Available Customization

The analyst offers customization according to your specific needs. The following customization options are available for the report:

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.